TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors

scientific article

TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/BI8005913
P698PubMed publication ID18540636
P5875ResearchGate publication ID5316077

P50authorLewis E. KayQ29046014
John L. RubinsteinQ43276745
Aaron SchimmerQ56378117
P2093author name stringXiaoming Li
Remco Sprangers
Xinliang Mao
P433issue26
P407language of work or nameEnglishQ1860
P304page(s)6727-6734
P577publication date2008-06-10
P1433published inBiochemistryQ764876
P1476titleTROSY-based NMR evidence for a novel class of 20S proteasome inhibitors
P478volume47

Reverse relations

cites work (P2860)
Q92284614Aromatic 19F-13C TROSY: a background-free approach to probe biomolecular structure, function, and dynamics
Q55401911Cationic porphyrins are tunable gatekeepers of the 20S proteasome.
Q26825417DangER: protein ovERload. Targeting protein degradation to treat myeloma
Q27660397Dynamic regulation of archaeal proteasome gate opening as studied by TROSY NMR
Q35063122Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.
Q33588424Effect of noncompetitive proteasome inhibition on bortezomib resistance
Q89865089Exploring long-range cooperativity in the 20S proteasome core particle from Thermoplasma acidophilum using methyl-TROSY-based NMR
Q39602920Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin
Q37365069Fundamental reaction pathway for peptide metabolism by proteasome: insights from first-principles quantum mechanical/molecular mechanical free energy calculations
Q38177328Harnessing proteasome dynamics and allostery in drug design.
Q90729473Improving yields of deuterated, methyl labeled protein by growing in H2O
Q37351110Inhibition of the human proteasome by imidazoline scaffolds
Q39287034Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.
Q35843506Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein
Q88962136Methyl group reorientation under ligand binding probed by pseudocontact shifts
Q26781075Methyl groups as NMR probes for biomolecular interactions
Q37604187Methyl groups as probes of supra-molecular structure, dynamics and function
Q39278628Molecular mechanisms of acquired proteasome inhibitor resistance
Q34490414N-terminal domain of human Hsp90 triggers binding to the cochaperone p23.
Q46064467NMR spectroscopy of soluble protein complexes at one mega-dalton and beyond
Q36691554Noncompetitive modulation of the proteasome by imidazoline scaffolds overcomes bortezomib resistance and delays MM tumor growth in vivo
Q37878771Novel proteasome inhibitors to overcome bortezomib resistance
Q34062354Nuclear magnetic resonance captures the elusive.
Q30428673PARAssign--paramagnetic NMR assignments of protein nuclei on the basis of pseudocontact shifts
Q36483667Proteasome allostery as a population shift between interchanging conformers
Q42058162Selective editing of Val and Leu methyl groups in high molecular weight protein NMR.
Q38081952Structural biology of the proteasome
Q35998619Substituted quinolines as noncovalent proteasome inhibitors.
Q34769338Synthesis and proteasome inhibition of lithocholic acid derivatives
Q38246060The future of proteasome inhibitors in relapsed/refractory multiple myeloma.
Q36721779The role of allostery in the ubiquitin-proteasome system

Search more.